Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2003
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368296A1 Fluorinated trienes and their use as rxr modulators
12/10/2003EP1368061A2 Fusion cells and cytokine compositions for treatment of disease
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368053A2 Compositions and methods for treating gonadotrophin related illnesses
12/10/2003EP1368038A1 Methods for the administration of amifostine and related compounds
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368034A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
12/10/2003EP1368031A2 Method of treating of demyelinating diseases or conditions
12/10/2003EP1368030A1 Epothilone derivatives for the treatment of refractory tumors
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/10/2003EP1368027A2 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
12/10/2003EP1368025A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
12/10/2003EP1368018A2 Use of sugar phosphate, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycolysis-enzyme complex, the malate-aspartate shuttle and/or transaminases
12/10/2003EP1368006A1 Novel modified released formulation
12/10/2003EP1368001A2 Pharmaceutical formulation comprising bicalutamide
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
12/10/2003EP1185276B1 Isophosphoramide mustard analogs and use thereof
12/10/2003EP1163243B1 Calanolides for inhibiting btk
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0958371B1 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/10/2003EP0754059B1 Methods and compositions useful for inhibition of angiogenesis
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003CN1461344A Multivalent target binding protein
12/10/2003CN1461342A Glycosylated VEGF-B and method for increasing amount of soluble VEFG-B
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461309A Inhibitory PAS domain protein (IPAS) and screening methods related to angiogenesis and tumor progression
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/10/2003CN1461207A Vaginal delivery of bisphosphonates
12/10/2003CN1460686A Method for preparing alpha-fetoglobulin transspecific factor
12/10/2003CN1460683A Oxalibo purification
12/10/2003CN1460522A Egg yolk antibody composite for preventing and curing diseases and its preparaion method
12/10/2003CN1460520A Compound alliin enteric solubility capsule
12/10/2003CN1460484A Bacillus prodigiosus polysaccharide for nose drops
12/10/2003CN1460475A Sophoridine soft capsule for curing malignant tumor and its preparation method
12/10/2003CN1460467A Adriamycin liposome hydrochloride for injection
12/10/2003CN1130364C Deuteroporphyvin derivative, its preparing method and freeze dried preparation for injection
12/10/2003CN1130356C Partially synthetic seco-taxinane with antitumour activity
12/10/2003CN1130217C Medicine for preventing and treating cancer and preparing method thereof
12/10/2003CN1130213C Chinese herbal plaster for anti-canser and analgesic
12/10/2003CN1130199C Improved method of synthesis for 6,9-bis[(2-aminoethyl)amino] benzo[g] isoquinoline-5,10-dione and its dimaleate salt
12/09/2003US6660891 Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom
12/09/2003US6660871 Synthesis of 4H-chromene derivatives
12/09/2003US6660866 C10 carbonate substituted taxanes
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660830 Peptides with antiproliferative properties
12/09/2003US6660767 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
12/09/2003US6660765 FC101 as a method of treatment for cancer
12/09/2003US6660764 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof
12/09/2003US6660763 Bis-indolylquinone compounds
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/09/2003US6660741 Coupling an O-protected methoxypyrrolidine or derivatives with N-protected amino acid 2,5-dioxo-pyrrolidinyl ester to form intermediate, deportecting with trifluoroacetic acid to form pyrrolidine-1-carbonyl-2-methylamine or derivatives
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660729 Particle-forming compositions containing fused pyrrolocarbazoles
12/09/2003US6660728 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/09/2003US6660723 Activating primate gamma delta lymphocytes
12/09/2003US6660722 Therapeutical treatments
12/09/2003US6660714 α-O-linked glycoconjugates, methods of preparation and uses thereof
12/09/2003US6660525 Therapeutic liposome composition and method
12/09/2003US6660521 Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus
12/09/2003US6660512 Human lysozyme gene, it's encoded polypeptide and the method of preparing them
12/09/2003US6660259 Herpes simplex virus for treating unwanted hyperproliferative cell growth
12/09/2003CA2264985C 6,8-dimercarptooctanoic acid derivatives substituted in 6-s and/or 8-s by the radical (3-methylthiopropanoyl) and pharmaceutical compositions used to treat cancerous tumors
12/09/2003CA2261772C Process and apparatus for the production of bi-212 and a use thereof
12/09/2003CA2140247C Novel vitamin d analogues
12/09/2003CA2103707C Treatment of non-small cell lung carcinoma
12/06/2003CA2389634A1 Fused tri-heterocyclic compounds
12/04/2003WO2003100438A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100432A2 Method for identifying immunoreactive peptides
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003100064A1 Novel ubiquitin ligase
12/04/2003WO2003100060A2 Muc-1 antigen with reduced number of vntr repeat units
12/04/2003WO2003100045A1 Plant thymidine kinases and their use
12/04/2003WO2003100040A1 A method for generating antigen-presenting cells
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100008A2 Neutralizing human anti-igfr antibody
12/04/2003WO2003099859A2 Novel use of adenoviruses and nucleic acids coding therefor
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099813A1 Novel physiolgically active substances
12/04/2003WO2003099812A1 Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine
12/04/2003WO2003099811A1 Kinase inhibitors
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099796A1 Protein kinase inhibitors
12/04/2003WO2003099788A1 Piperidine derivatives
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099340A1 Novel chimeric cd154
12/04/2003WO2003099333A1 Methods of controlling fertility, cancers and reproductive tract diseases
12/04/2003WO2003099327A1 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
1 ... 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 ... 2211